Brief: Marinus Pharmaceuticals Reports Q1 2023 Financial Results, Provides Business Update

Marinus Pharmaceuticals

11/05/2023 13:27

May 11 (Reuters) - Marinus Pharmaceuticals Inc  MRNS.O :
    * MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
FIRST QUARTER 2023 FINANCIAL RESULTS
    * SEES FY REVENUE $15.0 MILLION TO $17.0 MILLION
    * CASH RUNWAY INTO H2 OF 2024 WITH CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENTS OF $199.2 MILLION AS OF MARCH 31, 2023
    * QTRLY NET LOSS PER SHARE OF COMMON STOCK- BASIC AND
DILUTED
$0.67
    * Q1 EARNINGS PER SHARE VIEW $-0.72 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwbDTRVfa 
Further company coverage:  MRNS.O 

 ((Reuters.Briefs@thomsonreuters.com;))